Inspire Medical Systems Stock Today

INSP Stock  USD 192.76  1.24  0.64%   

Performance

4 of 100

 
Weak
 
Strong
Insignificant

Odds Of Distress

Less than 45

 
High
 
Low
Below Average
Inspire Medical is selling at 192.76 as of the 30th of November 2024; that is 0.64 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 189.25. Inspire Medical has 45 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. Equity ratings for Inspire Medical Systems are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
3rd of May 2018
Category
Healthcare
Classification
Health Care
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea in the United States and internationally. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota. The company has 29.97 M outstanding shares of which 2.24 M shares are currently shorted by private and institutional investors with about 4.1 trading days to cover. More on Inspire Medical Systems

Moving against Inspire Stock

  0.61DXCM DexCom Inc Sell-off TrendPairCorr
  0.59LH LaboratoryPairCorr
  0.55VREX Varex Imaging CorpPairCorr
  0.5OM Outset MedicalPairCorr
  0.47GH Guardant HealthPairCorr
  0.44MD Mednax IncPairCorr

Inspire Stock Highlights

ESG Sustainability
Environmental
Governance
Social
CEOTimothy Herbert
Old NameInspire Semiconductor Holdings Inc.
Business ConcentrationHealth Care Technology, Health Care Equipment & Services, Health Care, NYSE Composite, SP Small-Cap 600, Health Care, Health Care Technology, Medical Devices, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.810.9232
Fairly Down
Slightly volatile
Gross Profit Margin0.640.8454
Way Down
Slightly volatile
Total Current Liabilities82 M78.1 M
Sufficiently Up
Slightly volatile
Non Current Liabilities Total23.1 M26.2 M
Fairly Down
Slightly volatile
Total Assets710.7 M676.8 M
Sufficiently Up
Slightly volatile
Total Current Assets623.4 M593.7 M
Sufficiently Up
Slightly volatile
Debt Levels
Inspire Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Inspire Medical's financial leverage. It provides some insight into what part of Inspire Medical's total assets is financed by creditors.
Liquidity
Inspire Medical Systems currently holds 24.85 M in liabilities with Debt to Equity (D/E) ratio of 0.14, which may suggest the company is not taking enough advantage from borrowing. Inspire Medical Systems has a current ratio of 5.51, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Inspire Medical's use of debt, we should always consider it together with its cash and equity.

Change In Working Capital

(38.74 Million)
Inspire Medical Systems (INSP) is traded on New York Stock Exchange in USA. It is located in 5500 Wayzata Blvd., Golden Valley, MN, United States, 55416 and employs 1,011 people. Inspire Medical is listed under Health Care Technology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.78 B. Inspire Medical Systems conducts business under Health Care Technology sector and is part of Health Care industry. The entity has 29.97 M outstanding shares of which 2.24 M shares are currently shorted by private and institutional investors with about 4.1 trading days to cover. Inspire Medical Systems currently holds about 196.32 M in cash with 24.65 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.1.
Check Inspire Medical Probability Of Bankruptcy
Ownership Allocation
The majority of Inspire Medical Systems outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Inspire Medical to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Inspire Medical Systems. Please pay attention to any change in the institutional holdings of Inspire Medical Systems as this could imply that something significant has changed or is about to change at the company.
Check Inspire Ownership Details

Inspire Stock Institutional Holders

InstituionRecorded OnShares
Artisan Partners Limited Partnership2024-09-30
545.9 K
Amvescap Plc.2024-06-30
539.1 K
Morgan Stanley - Brokerage Accounts2024-06-30
514.8 K
Geode Capital Management, Llc2024-09-30
483.7 K
Hhg Plc2024-06-30
475.2 K
Champlain Investment Partners, Llc2024-09-30
464.6 K
Frontier Capital Management Co Inc2024-09-30
395 K
Ubs Asset Mgmt Americas Inc2024-09-30
365.2 K
T. Rowe Price Associates, Inc.2024-06-30
364.9 K
Vanguard Group Inc2024-09-30
3.2 M
Fmr Inc2024-09-30
2.9 M
View Inspire Medical Diagnostics

Inspire Medical Historical Income Statement

At this time, Inspire Medical's Cost Of Revenue is relatively stable compared to the past year. As of 11/30/2024, Total Operating Expenses is likely to grow to about 596.9 M, while Operating Income is likely to drop (42.3 M). View More Fundamentals

Inspire Stock Against Markets

Inspire Medical Corporate Directors

Georgia GarinoisMelenikiotouIndependent DirectorProfile
Megan CPADirector ReportingProfile
Shawn McCormickIndependent DirectorProfile
Jerry GriffinIndependent DirectorProfile

Additional Tools for Inspire Stock Analysis

When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.